PAMELA STEINBERG: Open Payments
NPI 1508820150 · LIVONIA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,976 in 85 payments from 18 companies in 2025. Trend: 2023 $2,154 · 2024 $1,504 · 2025 $1,976
Food & beverage: $1,864Education: $111
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $497 |
| GENZYME CORPORATION | 17 | $328 |
| Regeneron Healthcare Solutions, Inc. | 11 | $318 |
| Novartis Pharmaceuticals Corporation | 6 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $105 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $68 |
| CSL Behring | 3 | $64 |
| Viatris Specialty LLC | 2 | $58 |
| BioCryst US Sales Co., LLC | 2 | $56 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, AIRSUPRA, XOLAIR, NEFFY, Hizentra, YUPELRI.
Industry payments across MI — which companies pay providers there.
